TMPOP2, thymopoietin pseudogene 2, 100533619

N. diseases: 10; N. variants: 0
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0007847
Disease: Malignant tumor of cervix
Malignant tumor of cervix 		0.020 AlteredExpression disease BEFREE Together, our results indicate that TMPOP2 and HPV16/18 E6/E7 mutually strengthen their expression in cervical cancer cells to enhance tumorigenic activities.<b>IMPORTANCE</b> Human papillomaviruses 16 and 18 (HPV16/18) are the main causative agents of cervical cancer. 30728257 2019
CUI: C0302592
Disease: Cervix carcinoma
Cervix carcinoma 		0.020 AlteredExpression disease BEFREE Together, our results indicate that TMPOP2 and HPV16/18 E6/E7 mutually strengthen their expression in cervical cancer cells to enhance tumorigenic activities.<b>IMPORTANCE</b> Human papillomaviruses 16 and 18 (HPV16/18) are the main causative agents of cervical cancer. 30728257 2019
CUI: C4048328
Disease: cervical cancer
cervical cancer 		0.020 AlteredExpression disease BEFREE Together, our results indicate that TMPOP2 and HPV16/18 E6/E7 mutually strengthen their expression in cervical cancer cells to enhance tumorigenic activities.<b>IMPORTANCE</b> Human papillomaviruses 16 and 18 (HPV16/18) are the main causative agents of cervical cancer. 30728257 2019
CUI: C0007847
Disease: Malignant tumor of cervix
Malignant tumor of cervix 		0.020 Biomarker disease BEFREE We termed it as EZH2-binding lncRNA in cervical cancer [lncRNA-EBIC]. 25007342 2014
CUI: C0302592
Disease: Cervix carcinoma
Cervix carcinoma 		0.020 Biomarker disease BEFREE We termed it as EZH2-binding lncRNA in cervical cancer [lncRNA-EBIC]. 25007342 2014
CUI: C4048328
Disease: cervical cancer
cervical cancer 		0.020 Biomarker disease BEFREE We termed it as EZH2-binding lncRNA in cervical cancer [lncRNA-EBIC]. 25007342 2014
CUI: C0027651
Disease: Neoplasms
Neoplasms 		0.010 AlteredExpression group BEFREE Reciprocally, ectopic expression of TMPOP2 was demonstrated to sequester tumor repressor microRNAs (miRNAs) miR-375 and miR-139 which target HPV16/18 E6/E7 mRNA and resulted in an upregulation of HPV16/18 <i>E6/E7</i> genes. 30728257 2019
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms 		0.010 Biomarker group BEFREE Researches showed that lncRNA EBIC had played key roles in different cancer, but its role in ovarian cancer remains largely unclear. 30058681 2018
CUI: C0919267
Disease: ovarian neoplasm
ovarian neoplasm 		0.010 Biomarker disease BEFREE Researches showed that lncRNA EBIC had played key roles in different cancer, but its role in ovarian cancer remains largely unclear. 30058681 2018
CUI: C1140680
Disease: Malignant neoplasm of ovary
Malignant neoplasm of ovary 		0.010 Biomarker disease BEFREE Researches showed that lncRNA EBIC had played key roles in different cancer, but its role in ovarian cancer remains largely unclear. 30058681 2018
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm 		0.010 Biomarker group BEFREE Researches showed that lncRNA EBIC had played key roles in different cancer, but its role in ovarian cancer remains largely unclear. 30058681 2018
CUI: C4721610
Disease: Carcinoma, Ovarian Epithelial
Carcinoma, Ovarian Epithelial 		0.010 Biomarker disease BEFREE Researches showed that lncRNA EBIC had played key roles in different cancer, but its role in ovarian cancer remains largely unclear. 30058681 2018
CUI: C1269955
Disease: Tumor Cell Invasion
Tumor Cell Invasion 		0.010 Biomarker phenotype BEFREE We observed that the migration and invasion of cervical cancer cells in vitro were inhibited upon suppression of lncRNA-EBIC by siRNA. 25007342 2014